Overexpression of IGF2 in human HCC cells, results from the reactivation of the fetal promoter (P2–P4) pattern, downregulation or deletion of IGF2R, and/or downregulation of IGFBPs. Here, IGF2 is linked to hepatocellular carcinoma.